Search results
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
Morningstar· 4 days agoMs. Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent directorNORTH CHICAGO, Ill., June 20, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today ...
Central Bank & Trust Co. Has $609,000 Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 15 hours agoCentral Bank & Trust Co. decreased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% during the first quarter, according to its most recent filing with the Securities ...
Red Spruce Capital LLC Acquires 62 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoRed Spruce Capital LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 49,680 ...
AbbVie Declares Quarterly Dividend
Morningstar· 3 days agoNORTH CHICAGO, Ill., June 21, 2024 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share. The cash ...
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 6 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
Congress Asset Management Co. MA Decreases Stock Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoCongress Asset Management Co. MA lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.4% during the first quarter, according to the company in its most ...
Tealwood Asset Management Inc. Acquires 106 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoTealwood Asset Management Inc. grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent 13F filing ...
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 4 days agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 4 days agoSupported by robust data from two Phase 3 clinical trials, INSPIRE and COMMAND, the approval highlights Skyrizi’s potential to become a cornerstone therapy in AbbVie’s portfolio ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by Pathway Financial Advisors LLC
ETF DAILY NEWS· 2 days agoPathway Financial Advisors LLC raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the SEC. The ...
